The number of transmitter molecules released in a quantal event can be regulated, and recent studies suggest that the modulation of quantal size is associated with corresponding changes in vesicle volume (Colliver et al., 2000; Pothos et al., 2002). If so, this could occur either by distension of the vesicle membrane or by incorporation and removal of vesicle membrane. We performed simultaneous measurements of vesicle membrane area and catecholamine release in individual quantal events from chromaffin cells using cellattached patch amperometry. Cells were treated with reserpine, a vesicular monoamine transport blocker that decreases quantal size, or L-dopa, a catecholamine precursor that increases quantal size. We show that decrease and increase in quantal size are associated with a respective decrease and increase in vesicle membrane area. These results point to a novel mechanism of vesicle membrane dynamics by which vesicles physically change their membrane area in response to changes in transmitter content such that the intravesicular concentration of transmitter is maintained.
Introduction
In most neurons, the postsynaptic response to released neurotransmitter from single vesicles shows significant variations in amplitude (Bekkers et al., 1990; Liu et al., 1999) . Such variability may reflect presynaptic or postsynaptic mechanisms, or both (Auger and Marty, 2000) . Evidence has been presented that quantal response is limited by availability of postsynaptic receptors (Tang et al., 1994; Auger and Marty, 1997) ; however, other studies suggest that quantal variability is caused by variations in the amount of transmitter released per synaptic vesicle fusion event (Frerking et al., 1995; Liu et al., 1999) . Various studies indicated that variability in quantal size reflects the vesicle size distribution, whereas the transmitter concentration inside the vesicles is constant (Van der Kloot and Molgo, 1994; Finnegan et al., 1996; Albillos et al., 1997; Bruns et al., 2000) .
Manipulations affecting the loading of vesicles with transmitter modulate quantal size . In the neuromuscular junction and midbrain dopamine neurons, a marked increase in the amplitude of miniature excitatory postsynaptic currents is induced by overexpression of vesicular neurotransmitter transporters, suggesting that quantal size can be regulated by changes in vesicular transporter activity (Song et al., 1997; Pothos et al., 2000) . In dopaminergic neurons and PC12 cells, the catecholamine precursor L-dopa increases quantal size by enhancing formation of cytosolic dopamine (Pothos et al., 1996 (Pothos et al., , 1998 , whereas the vesicular monoamine transport inhibitor reserpine decreases quantal size (Kozminski et al., 1998; Pothos et al., 1998) .
If the concentration within vesicles remains constant, this poses an obvious problem for mechanisms that change quantal size by altering the number of transmitter molecules within secretory vesicles. The volume of secretory vesicles must change. Using amperometry and transmission electron microscopy, it was suggested that the alterations of quantal size by L-dopa and reserpine treatment were associated with swelling and shrinking of vesicles, respectively (Colliver et al., 2000) . In chromaffin cells, manipulations that enhance vesicular pH gradients lead to an increase in both quantal size and vesicle volume, whereas conditions that collapse vesicle pH gradients decrease quantal size and vesicle volume (Pothos et al., 2002) .
Swelling and shrinking of vesicles could occur by stretching and undulating the membrane of the vesicle or through incorporation and loss of membrane. Because the area of a cell membrane can be stretched by only ϳ3% (Evans et al., 1976) , the former mechanism does not involve significant changes in membrane area, whereas the latter mechanism does. Membrane capacitance measurements provide a direct assay of changes in membrane area (Neher and Marty, 1982) . Cell-attached patch amperometry combines patch-clamp measurements of capacitance steps, indicating vesicle membrane area (Neher and Marty, 1982) , with amperometric detection of released catecholamines by a carbon fiber electrode (Wightman et al., 1991; Chow et al., 1992) located inside the patch pipette (Albillos et al., 1997) . We used this method for simultaneous measurements of vesicle membrane area and the amount of catecholamine secreted from the same vesicle. We found that vesicle membrane area changes markedly in parallel with changes in quantal size.
Materials and Methods
Cells and recording configurations. Bovine chromaffin cells were prepared and cultured as described (Parsons et al., 1995) . Cell-attached patch amperometry recordings were performed using the method described previously (Albillos et al., 1997) on days 1-4 in culture. The patch pipette contained a carbon fiber electrode and an Ag/AgCl reference electrode for amperometric detection of catecholamines released into the pipette because of exocytosis in the cell-attached patch. The sine wave for patch capacitance measurements was applied to the bath. Changes of patch admittance were measured with a lock-in amplifier (SR 830, Stanford Research Systems) using a 20 kHz, 50 mV (root mean square) sine wave.
Whole-cell capacitance measurements were performed using cells with 15-17 m diameter by adjustment of the C-slow capacitance compensation circuitry of a HEKA EPC-8 amplifier using a 5 mV square pulse.
Reagents and solutions. The bath solution contained (in mM): 140 NaCl, 5 KCl, 5 CaCl 2 , 1 MgCl 2 , 10 HEPES/NaOH, 10 glucose, pH 7.3. For cell-attached patch amperometry the pipette solution contained (in mM): 50 NaCl, 100 TEA-Cl, 5 KCl, 10 CaCl 2 , 1 MgCl 2 , 10 HEPES/NaOH, pH 7.3. For whole-cell capacitance measurements the pipette contained solution contained (in mM): 140 K-glutamate, 8 NaCl, 1 MgCl 2 , 0.1 EGTA, 1 Mg-ATP, 0.3 Na 2 GTP, 15 HEPES/KOH, pH 7.30. Chromaffin cells were treated with 100 M L-dopa, 1 M reserpine, or (for controls) with the same amount of physiological saline or dimethylsulfoxide (DMSO) in bath solution for 60 min at room temperature. L-Dopa or reserpine was added from a 10 mM stock solution in physiological saline or 1 mM in DMSO, respectively. After treatment, the cells were transferred to bath solution without drug and allowed 20 min to recover before recording. All recordings were completed within 1-2 hr after the incubation period.
Data analysis. The number of catecholamine molecules in a vesicle (quantal size) was determined by integrating the amperometric current of a single event after baseline subtraction and dividing the resulting charge by 2e 0 (e 0 ϭ elementary charge), assuming that two electrons are transferred per molecule (Baur et al., 1988) . The volume of the individual vesicles was calculated using a specific capacitance of 9 fF/m 2 (Albillos et al., 1997) and assuming spherical geometry. To determine the average vesicular concentrations, quantal size was plotted as a function of vesicle volume for each vesicle, and a straight line through the origin was fitted to the data points. The slope of the fit provides the average concentration and the correlation coefficient provides an indication of the variability. Such fits were performed for pooled data as well as for single cells as described in Results.
Results
To simultaneously measure quantal size and vesicle membrane area we performed cell-attached patch amperometry capacitance measurements. Capacitance steps associated with amperometric spikes (Fig. 1) indicate exocytosis of individual chromaffin granules. The membrane area of individual exocytosed granules is proportional to the size of capacitance steps. The number of catecholamine molecules in a vesicle is obtained by integrating the amperometric current of the same vesicle after baseline subtraction ( Fig. 1 ) and dividing the resulting charge by 2e 0 , assuming that two electrons are transferred per molecule (Baur et al., 1988) .
L-Dopa and reserpine change quantal size
In control cells, the average amperometric charge was 1.81 Ϯ 0.14 pC, corresponding to 5.7 Ϯ 0.4 ϫ 10 6 molecules per vesicle. As expected, incubation of the cells for 1 hr in the presence of 100 M L-dopa increased the average quantal size by 70% to 3.05 Ϯ 0.26 pC or 9.4 Ϯ 0.8 ϫ 10 6 molecules per vesicle. In contrast, a 1 hr treatment with 1 M reserpine decreased quantal size by 30% to 1.22 Ϯ 0.1 pC or 3.8 Ϯ 0.3 ϫ 10 6 molecules per vesicle (Fig. 2 A) . These mean values were obtained from catecholaminecontaining vesicles only. In addition, some catecholamine-free vesicles are released, indicated by capacitance steps that were not associated with an amperometric spike. The fraction of catecholamine-free vesicles was 8% in control cells (12 of 153), 6% in L-dopa-treated cells (8 of 129), and increased to 19% in reserpine-treated cells (22 of 115), confirming previous observations in rat chromaffin cells (Tabares et al., 2001 ).
L-Dopa and reserpine change vesicle membrane area
The average capacitance step size of catecholamine-containing vesicles in control cells was 1.64 Ϯ 0.08 fF. Interestingly, the average step size was 41% higher in L-dopa-treated cells (2.31 Ϯ 0.11 fF) and 16% lower in reserpine-treated cells (1.37 Ϯ 0.08 fF) (Fig. 2 B) . A comparison between capacitance step size distributions and morphometric analysis revealed a specific capacitance of 9 fF/m 2 for granules of cultured bovine chromaffin cells (Albillos et al., 1997) . The average membrane area of exocytosed granules is thus 0.182 Ϯ 0.009 m 2 in control cells, 0.257 Ϯ 0.012 m 2 in L-dopa-treated cells, and 0.152 Ϯ 0.009 m 2 in reserpine-treated cells. Thus, the changes in vesicle volumes associated with changes in quantal size are caused by incorporation and removal of vesicle membrane. The average step size of catecholamine-free vesicles was smaller (0.60 Ϯ 0.09 fF; n ϭ 42), corresponding to an average vesicle membrane area of 0.067 Ϯ 0.01 m 2 for empty vesicles.
Vesicular catecholamine concentrations remain constant
The average vesicle volume in control cells was 8.2 Ϯ 0.73 al. L-Dopa increased the average volume by 62% to 13.3 Ϯ 1.1 al, and reserpine decreased the average volume by 24% to 6.2 Ϯ 0.6 al (Fig. 2C ). Both L-dopa and reserpine had no significant effects on vesicular catecholamine concentrations (Fig. 2 D) , although they both significantly changed quantal size and the vesicle membrane area. Figure 3 A, C,E shows proportional relationships between quantal size and vesicle volume for all exocytotic events in each group as expected for constant vesicle concentration. In control cells (Fig.  3A ) the average vesicular concentration (slope) was 1.03 Ϯ 0.06 M, with a correlation coefficient of 0.78. The variability in vesicular concentration is much smaller in individual cells (Albillos et al., 1997) . The fit for the single cell shown in Figure 3B gave a correlation coefficient of 0.92. Correlation coefficients were determined for each cell with three or more events. The median of correlation coefficients in individual cells was 0.92 for control cells (n ϭ 16 cells). Thus, most of the scatter in Figure 3A comes from cell-to-cell variability. L-Dopa-treated cells (Fig. 3C ) gave a correlation coefficient of 0.90 in the ensemble and a median correlation coefficient of 0.96 (n ϭ 13 cells) in individual cells (Fig.  3D ). In contrast, reserpine treatment (Fig. 3E ) gave a much lower correlation coefficient (0.61) in the ensemble. The increased scatter in vesicular concentrations is also seen on the single cell level (Fig. 3F ) , with a median correlation coefficient of 0.63 (n ϭ 8 cells). These results indicate a systematic change in variability of vesicular concentrations on the single cell level.
Variability of vesicular concentrations is modulated by L-dopa and reserpine

Discussion
Using cell-attached patch amperometry we have shown that the increase in quantal size observed in cells treated with L-dopa and the decrease in quantal size in cells treated with reserpine are accompanied by a corresponding increase and decrease in capacitance step sizes under the different conditions. The capacitance step size distribution in cultured bovine chromaffin cells is in excellent agreement with morphometric analysis of vesicle profiles in thin sections when a specific capacitance of 9 fF/m 2 is used to convert capacitance step size into vesicle membrane area (Albillos et al., 1997) . We thus interpret the increased capacitance step sizes in L-dopa-treated cells and the decreased capacitance step sizes in reserpine-treated cells as changes in vesicle membrane area.
Could there be an alternative explanation for the change in capacitance step sizes in L-dopa and reserpine-treated cells? In principle, two other phenomena could underlie this observation. One possibility would be that in L-dopa-treated cells preferentially large vesicles are released and that in reserpine-treated cells preferentially small vesicles are released. This would mean that with these treatments neither vesicle membrane area nor vesicle contents change but that these treatments instead would selectively make small or large vesicles available for exocytosis. We consider this possibility mechanistically very unlikely, and furthermore reserpine-treated cells release increasing amounts of catecholamine-free vesicles (Tabares et al., 2001) , indicating that vesicular contents do change. In addition to membrane area, vesicle capacitance depends on the value of the specific capacitance (C S ). Another possibility would thus be that L-dopa and reserpine change C S . For example, hydrophobic ions that incorporate into membranes can affect C S of mast cell granules (Ober- hauser and Fernandez, 1995); however, such treatments affect not only the capacitance of the granules but also the capacitance of the plasma membrane (Oberhauser and Fernandez, 1995) . We thus measured in the whole-cell configuration the plasma membrane capacitance of chromaffin cells treated with L-dopa and of control cells of similar size. The mean plasma membrane capacitance of L-dopa-treated cells was 6.6 Ϯ 0.15 pF (SEM; n ϭ 9 cells) and was not significantly different from that of control cells (6.8 Ϯ 0.33 pF; SEM; n ϭ 8 cells). Thus, L-dopa treatment does not change C S , and the observed increase in capacitance step sizes in L-dopa-treated cells reflects an increase in vesicle membrane area. The 41% increase in vesicle membrane area and associated volume increase should be observable by electron microscopy. Indeed, such evidence has been reported previously (Colliver et al., 2000) . Both the ultrastructural studies combined with amperometric recordings and our patch amperometry recordings lead to the same conclusion that the change in quantal size is associated with a change in vesicle volume. Our results provide a mechanistic explanation for the vesicle volume changes and show that the physical vesicle membrane area is dynamic. Changes in catecholamine content may lead to changes in osmotic pressure. The maximal fractional area increase of biological membranes before lysis occurs is ϳ2-4% (Evans et al., 1976) and cannot explain the observed 41% increase of vesicle membrane area that occurs during incubation with L-dopa. The increase or decrease in quantal size must thus be associated with a physical addition or removal of parts of the vesicle membrane, respectively. Unusually large vesicles were also observed in rat basophilic leukemia cells after prolonged incubation with serotonin (Williams et al., 1999) .
Changes in quantal size are not explained by compound exocytosis
One way to increase vesicle size would be via compound exocytosis, in which vesicles would fuse inside the cell forming multivesicular compounds leading to increased capacitance steps (Scepek and Lindau, 1993) and increased quantal size. If compound exocytosis were the cause of increased vesicle membrane area and quantal size, we would expect a proportional increase of quantal size and membrane area. In contrast, a 43% increase of average vesicle membrane area is associated with a 70% increase of average quantal size in L-dopa-treated cells. For instance, the two largest events in Figure 3D represent vesicles with a membrane area of ϳ0.46 m 2 . If these were each formed by fusion of two vesicles with area 0.23 m 2 , then each of these smaller vesicles would have a volume of 10 al and a quantal size of 12 amol. The compound would have a quantal size of 24 amol and would deviate markedly from the straight line. In contrast, the data points for the large vesicles are on the same straight lines as the small ones (Fig. 3) , with a quantal size of ϳ33 amol. The observed proportional relation between vesicle volume and quantal size is thus not consistent with compound exocytosis as an explanation for events with large quantal size.
Vesicular membrane dynamics regulated by vesicle loading
The fact that reserpine decreases quantal size as well a vesicular membrane area suggests that the modulation of vesicle size may occur by a different mechanism. It appears that vesicle membrane can physically be added or removed. The average step size of catecholamine-free vesicles was 0.6 fF, significantly smaller than that of catecholamine-containing vesicles. A step size of 0.6 fF converts to a vesicle diameter of ϳ150 nm, which is very close to the size of catecholamine-free vesicles in rat chromaffin cells (Tabares et al., 2001) . It thus appears that there is a lower size limit to which chromaffin vesicles can be reduced. Over a wide range of concentrations, however, the vesicles can regulate their size such that their catecholamine concentration remains fairly constant after changes in vesicular catecholamine content. In L-dopa-treated cells, transport into the vesicles and quantal size are increased but there is no significant increase in vesicular concentration. Interestingly, the variability of vesicular concentration is decreased under these conditions, suggesting that the addition of vesicle membrane area is tightly coupled to the increase in quantal size. When the uptake is inhibited by reserpine, quantal size decreases as does vesicle membrane area, but the vesicular concentrations become more variable. The mechanism decreasing vesicular membrane area may thus be less tightly coupled to the decrease in quantal size.
We conclude that although vesicular catecholamine concentrations may vary from one cell to another (Albillos et al., 1997; Alés et al., 1999) , chromaffin granules have a mechanism to add or remove parts of their membrane area when catecholamine contents are increased or decreased. This allows marked changes in average quantal size whereas the average vesicular concentration is kept at a constant level. Our results clearly indicate that membrane is selectively added to or subtracted from vesicles, in contrast to volume changes caused by altered membrane tension or undulation. The mechanism of vesicular membrane dynamics is presently unknown. The increase and decrease in vesicle membrane area could be produced by a change in osmotic pressure resulting from changes in vesicular content. A rapid exoendocytosis cycle driven by pressure changes has been reported in plant cell protoplasts (Zorec and Tester, 1993; Homann and Thiel, 2002) and may be a general mechanism of plasma membrane area regulation in various cell types including neurons (Morris and Homann, 2001) , where increased osmotic pressure and membrane tension promote net exocytosis; decreased osmotic pressure and membrane tension promote net endocytosis (Dai et al., 1998) . Alternatively, specific interactions of cargo molecules with low-affinity receptors in the vesicle membrane may regulate vesicle membrane dynamics. Previous electron microscopy studies of adrenal cell vesicles showed small microvesicles present between the dense core and the vesicle membrane (Ornberg et al., 1986) . These intragranule microvesicles could contribute the material required to expand chromaffin granule membranes when granules are loaded with increased amounts of catecholamine; however, such intragranule vesicles were not reported in other studies (Plattner et al., 1997; Koval et al., 2001 ).
Another possibility is that cytosolic phospholipid transport proteins contribute to the changes in vesicle membrane area. An example is phosphatidylinositol transfer protein, which plays a role in secretory vesicle formation (Ohashi et al., 1995) . Osmotically induced granule swelling and shrinking have been studied by direct observation for the large secretory granules from beige mouse mast cells (Brodwick et al., 1992) . It was found that in disrupted cells, hypotonic swelling of secretory granules was limited to 8% before the vesicle lysed. In contrast, secretory vesicles in intact cells could swell by ϳ50% (Brodwick et al., 1992) . This suggests that the source of the added vesicle membrane may be cytosolic.
In addition to phospholipid transport proteins, vesicle membrane could be added by direct fusion or budding of small vesicles with chromaffin granules. In L-dopa-loaded cells, the average capacitance step size increases by 0.67 fF. Ultrastructural studies have shown that chromaffin cells contain multiple types of vesicles (Koval et al., 2001 ). Small synaptic-like microvesicles (SLMVs) have a mean diameter of 64 nm (Koval et al., 2001) corresponding to ϳ0.12 fF per SLMV. Approximately five or six such vesicles must fuse with a chromaffin granule to produce the observed increase in membrane area; however, the number of such vesicles in unstimulated cells is small (Koval et al., 2001 ). Chromaffin cells also contain small dense-core vesicles (SDCGs) with a mean diameter of 72 nm corresponding to ϳ0.15 fF per vesicle that are more numerous (Koval et al., 2001 ). These vesicles were seen to bud from the Golgi and also from large dense-core granules. SDCGs may thus represent the organelles mediating chromaffin granule membrane dynamics regulated by transmitter loading.
